What are the Challenges in Targeting RB in Cancer?
Despite promising strategies, several challenges remain in targeting RB in cancer. These include the complexity of the cell cycle regulation, potential side effects of CDK inhibitors, and difficulties in efficiently delivering gene therapy. Additionally, tumors often have multiple genetic alterations, and targeting RB alone may not be sufficient to halt tumor progression.
